_version_ 1784636269916061696
author Oliver, Sara E.
Wallace, Megan
See, Isaac
Mbaeyi, Sarah
Godfrey, Monica
Hadler, Stephen C.
Jatlaoui, Tara C.
Twentyman, Evelyn
Hughes, Michelle M.
Rao, Agam K.
Fiore, Anthony
Su, John R.
Broder, Karen R.
Shimabukuro, Tom
Lale, Allison
Shay, David K.
Markowitz, Lauri E.
Wharton, Melinda
Bell, Beth P.
Brooks, Oliver
McNally, Veronica
Lee, Grace M.
Talbot, H. Keipp
Daley, Matthew F.
author_facet Oliver, Sara E.
Wallace, Megan
See, Isaac
Mbaeyi, Sarah
Godfrey, Monica
Hadler, Stephen C.
Jatlaoui, Tara C.
Twentyman, Evelyn
Hughes, Michelle M.
Rao, Agam K.
Fiore, Anthony
Su, John R.
Broder, Karen R.
Shimabukuro, Tom
Lale, Allison
Shay, David K.
Markowitz, Lauri E.
Wharton, Melinda
Bell, Beth P.
Brooks, Oliver
McNally, Veronica
Lee, Grace M.
Talbot, H. Keipp
Daley, Matthew F.
author_sort Oliver, Sara E.
collection PubMed
description
format Online
Article
Text
id pubmed-8774160
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-87741602022-01-28 Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021 Oliver, Sara E. Wallace, Megan See, Isaac Mbaeyi, Sarah Godfrey, Monica Hadler, Stephen C. Jatlaoui, Tara C. Twentyman, Evelyn Hughes, Michelle M. Rao, Agam K. Fiore, Anthony Su, John R. Broder, Karen R. Shimabukuro, Tom Lale, Allison Shay, David K. Markowitz, Lauri E. Wharton, Melinda Bell, Beth P. Brooks, Oliver McNally, Veronica Lee, Grace M. Talbot, H. Keipp Daley, Matthew F. MMWR Morb Mortal Wkly Rep Full Report Centers for Disease Control and Prevention 2022-01-21 /pmc/articles/PMC8774160/ /pubmed/35051137 http://dx.doi.org/10.15585/mmwr.mm7103a4 Text en https://creativecommons.org/publicdomain/zero/1.0/All material in the MMWR Series is in the public domain and may be used and reprinted without permission; citation as to source, however, is appreciated.
spellingShingle Full Report
Oliver, Sara E.
Wallace, Megan
See, Isaac
Mbaeyi, Sarah
Godfrey, Monica
Hadler, Stephen C.
Jatlaoui, Tara C.
Twentyman, Evelyn
Hughes, Michelle M.
Rao, Agam K.
Fiore, Anthony
Su, John R.
Broder, Karen R.
Shimabukuro, Tom
Lale, Allison
Shay, David K.
Markowitz, Lauri E.
Wharton, Melinda
Bell, Beth P.
Brooks, Oliver
McNally, Veronica
Lee, Grace M.
Talbot, H. Keipp
Daley, Matthew F.
Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
title Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
title_full Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
title_fullStr Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
title_full_unstemmed Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
title_short Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
title_sort use of the janssen (johnson & johnson) covid-19 vaccine: updated interim recommendations from the advisory committee on immunization practices — united states, december 2021
topic Full Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8774160/
https://www.ncbi.nlm.nih.gov/pubmed/35051137
http://dx.doi.org/10.15585/mmwr.mm7103a4
work_keys_str_mv AT oliversarae useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT wallacemegan useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT seeisaac useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT mbaeyisarah useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT godfreymonica useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT hadlerstephenc useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT jatlaouitarac useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT twentymanevelyn useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT hughesmichellem useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT raoagamk useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT fioreanthony useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT sujohnr useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT broderkarenr useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT shimabukurotom useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT laleallison useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT shaydavidk useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT markowitzlaurie useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT whartonmelinda useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT bellbethp useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT brooksoliver useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT mcnallyveronica useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT leegracem useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT talbothkeipp useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021
AT daleymatthewf useofthejanssenjohnsonjohnsoncovid19vaccineupdatedinterimrecommendationsfromtheadvisorycommitteeonimmunizationpracticesunitedstatesdecember2021